GE

Genomictree Inc.

Develops molecular diagnostics using DNA methylation biomarkers for early cancer detection.

228760 | KO

Overview

Corporate Details

ISIN(s):
KR7228760005
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크노10로 44-6, 대전광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Genomictree Inc. is a biomarker-based molecular diagnostics company focused on developing and commercializing products for the early detection of cancer. The company specializes in identifying and utilizing DNA methylation biomarkers through its proprietary genomic-scale discovery tools. Its flagship product line, EarlyTect®, includes tests for the early screening of colorectal, lung, and bladder cancers. Genomictree also offers AccuraTect™ for companion diagnostics. The company's mission is to improve patient quality of life and reduce overall medical costs by providing innovative and accurate molecular diagnostic solutions to address unmet needs in the healthcare industry.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-06-18 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.7 KB
2025-06-18 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.7 KB
2025-06-18 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.5 KB
2025-06-18 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.5 KB
2025-06-16 00:00
Transaction in Own Shares
자기주식처분결과보고서
Korean 16.7 KB
2025-06-11 00:00
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
Korean 29.1 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.3 MB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 17.9 KB
2025-03-18 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 556.0 KB
2025-03-14 00:00
Audit Report / Information
감사보고서제출
Korean 24.9 KB
2025-03-12 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 148.6 KB
2025-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 6.9 KB
2025-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 145.7 KB
2025-03-11 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 149.7 KB

Automate Your Workflow. Get a real-time feed of all Genomictree Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Genomictree Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Genomictree Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

AIM ImmunoTech Inc. Logo
Develops immuno-therapeutics for cancers, immune disorders, and viral diseases.
United States of America
AIM
AKANDA CORP. Logo
Cultivates and distributes pharma-quality medical cannabis for patients in legal markets worldwide.
United States of America
AKAN
Akari Therapeutics Plc Logo
A clinical-stage oncology company developing next-gen ADCs for targeted cancer therapy.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
Developing and commercializing novel, FDA-approved therapeutics for kidney disease.
United States of America
AKBA
Akero Therapeutics, Inc. Logo
A clinical-stage biotech developing therapies for serious metabolic diseases like MASH.
United States of America
AKRO
Alaunos Therapeutics, Inc. Logo
Developing TCR-T cell therapies to treat solid tumors by targeting specific cancer mutations.
United States of America
TCRT
Aldeyra Therapeutics, Inc. Logo
Biotech developing therapies for ocular and systemic immune-mediated inflammation.
United States of America
ALDX
Alector, Inc. Logo
Pioneers immuno-neurology therapies for neurodegenerative diseases like Alzheimer's.
United States of America
ALEC
Aligos Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel oral therapies for liver and viral diseases.
United States of America
ALGS
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark
ALK

Talk to a Data Expert

Have a question? We'll get back to you promptly.